Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.

about

Hydrogen bonding and anticancer properties of water-soluble chiral p-cymene Ru(II) compounds with amino-oxime ligands

P2860

Q28834484-702C2471-6B85-4B9E-ACD2-10F3D583303B

P2860

Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.

Item

http://www.wikidata.org/entity/Q38942212

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.

@en

type

Item

label

Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.

@en

prefLabel

Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.

@en

P1476

Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.

@en

P2093

Damijana Urankar

http://www.w3.org/2001/XMLSchema#string

David Schweinfurth

http://www.w3.org/2001/XMLSchema#string

Maja Osmak

http://www.w3.org/2001/XMLSchema#string

Martina Bubrin

http://www.w3.org/2001/XMLSchema#string

Michael G Sommer

http://www.w3.org/2001/XMLSchema#string

Petra Kureljak

http://www.w3.org/2001/XMLSchema#string

P2860

Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity.

Glutathione in cancer biology and therapy

Reactive oxygen species, cellular redox systems, and apoptosis

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Ruthenium-based chemotherapeutics: are they ready for prime time?

Organometallic anticancer compounds

The potent oxidant anticancer activity of organoiridium catalysts.

The contrasting activity of iodido versus chlorido ruthenium and osmium arene azo- and imino-pyridine anticancer complexes: control of cell selectivity, cross-resistance, p53 dependence, and apoptosis pathway.

Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.

Metal-based antitumour drugs in the post genomic era.

P304

17296-17299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CHEM.201404448

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267812140

http://www.w3.org/2001/XMLSchema#string

P698

25376425

http://www.w3.org/2001/XMLSchema#string

Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.

about

P2860

P2860

Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698